Literature DB >> 14701804

Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome.

Ian R Logan1, Vasileia Sapountzi, Luke Gaughan, David E Neal, Craig N Robson.   

Abstract

Murine PIRH2 (mPIRH2) was recently identified as a RING finger-containing ubiquitin-protein isopeptide ligase that interacts with both p53 and the human androgen receptor. mpirh2 is a p53-responsive gene that is up-regulated by UV, and mPIRH2 protein has the capacity to polyubiquitylate p53, perhaps leading to p53 destruction. mpirh2 therefore has properties similar to those of the oncogene mdm2. Here, we have identified human PIRH2 (hPIRH2) as a TIP60-interacting protein. To investigate its regulation, we characterized hPIRH2 in parallel with hPIRH2 variants possessing mutations of conserved RING finger residues. We observed that wild-type hPIRH2 is an unstable protein with a short half-life and is a target for RING domain-dependent proteasomal degradation. Accordingly, we found that hPIRH2 was ubiquitylated in cells. The TIP60-hPIRH2 association appeared to regulate hPIRH2 stability; coexpression of TIP60 enhanced hPIRH2 protein stability and altered hPIRH2 subcellular localization. These results suggest that hPIRH2 activities can be controlled, at the post-translational level, in multiple ways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14701804     DOI: 10.1074/jbc.M312712200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

Authors:  Lan Wang; Guifen He; Pingzhao Zhang; Xiang Wang; Mei Jiang; Long Yu
Journal:  Mol Biol Rep       Date:  2010-03-24       Impact factor: 2.316

2.  Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

Authors:  Valerie Edmond; Elodie Moysan; Saadi Khochbin; Patrick Matthias; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri; Beatrice Eymin
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

3.  Stability of Nmi protein is controlled by its association with Tip60.

Authors:  Keman Zhang; Gang Zheng; Yu-Chung Yang
Journal:  Mol Cell Biochem       Date:  2007-04-04       Impact factor: 3.396

4.  Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway.

Authors:  James Hejna; Megan Holtorf; Jennie Hines; Lauren Mathewson; Aaron Hemphill; Muhsen Al-Dhalimy; Susan B Olson; Robb E Moses
Journal:  J Biol Chem       Date:  2008-02-08       Impact factor: 5.157

5.  Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.

Authors:  Chad A Corcoran; JoAnne Montalbano; Hong Sun; Qin He; Ying Huang; M Saeed Sheikh
Journal:  J Biol Chem       Date:  2009-05-29       Impact factor: 5.157

6.  Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.

Authors:  Yong-Sam Jung; Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

7.  The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity.

Authors:  Erin A Kimbrel; Andrew L Kung
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

8.  PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.

Authors:  Gang Zheng; Jinying Ning; Yu-Chung Yang
Journal:  Biochem Biophys Res Commun       Date:  2007-10-11       Impact factor: 3.575

9.  Impact of siRNA targeting pirh2 on proliferation and cell cycle control of the lung adenocarcinoma cell line A549.

Authors:  Yuan Su; Liping Zhu; Yang Jin; Xiaoju Zhang; Qiong Zhou; Ming Bai
Journal:  Front Med China       Date:  2007-10-01

10.  Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies.

Authors:  Prabhakar Rajan; Caroline Dalgliesh; Cyril F Bourgeois; Monika Heiner; Kaveh Emami; Emma L Clark; Albrecht Bindereif; James Stevenin; Craig N Robson; Hing Y Leung; David J Elliott
Journal:  BMC Cell Biol       Date:  2009-11-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.